U S PHYSICAL THERAPY INC /NV
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $453.9M | $414.1M | $356.5M | $331.3M | $305.1M | $264.1M | $249.7M | $231.5M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $101.7M | $90.6M | $82.0M | $78.4M | $76.2M | $64.7M | $62.9M | $55.9M |
| Gross Margin | 22.4% | 21.9% | 23.0% | 23.7% | 25.0% | 24.5% | 25.2% | 24.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $41.3M | $35.9M | $32.5M | $31.1M | $30.4M | $25.9M | — | — |
| Operating Income | $60.3M | $54.7M | $49.5M | $47.3M | $45.8M | $38.8M | $38.4M | $31.4M |
| Operating Margin | 13.3% | 13.2% | 13.9% | 14.3% | 15.0% | 14.7% | 15.4% | 13.6% |
| Interest Expense | $2.0M | $21.1M | $11.5M | $7.2M | $7.5M | $538.0K | $557.0K | $496.0K |
| Pretax Income | $60.2M | $33.8M | $38.1M | $40.1M | $38.3M | $38.2M | $37.9M | $36.4M |
| Income Tax Expense | $11.4M | $6.0M | $11.9M | $13.6M | $13.0M | $12.2M | $11.2M | $9.7M |
| Net Income | $34.9M | $22.3M | $20.6M | $20.6M | $19.1M | $12.7M | $17.9M | $21.0M |
| Net Margin | 7.7% | 5.4% | 5.8% | 6.2% | 6.3% | 4.8% | 7.2% | 9.1% |
| EPS (Basic) | $1.31 | $1.76 | $1.64 | $1.77 | $1.62 | $1.05 | $1.52 | $1.78 |
| EPS (Diluted) | $1.31 | $1.76 | $1.64 | $1.77 | $1.62 | $1.05 | $1.51 | $1.75 |
| Shares Outstanding (Basic) | 12.7M | 12.6M | 12.5M | 12.4M | 12.2M | 12.1M | 11.8M | 11.8M |
| Shares Outstanding (Diluted) | 12.7M | 12.6M | 12.5M | 12.4M | 12.2M | 12.1M | 11.9M | 12.0M |
| Dividends Per Share | $0.92 | $0.80 | $0.68 | $0.60 | $0.48 | $0.40 | $0.76 | $0.32 |